PLGA-lecthin-PEG-folate Core-shell Nanoparticles for Cisplatin-prodrug Targeted Delivery
文献类型：会议论文
| 作者 | Mingbin Zheng; Ping Gong; Dongxue Jia; Yangyang Lu; Cuifang Zheng; Pengfei Zhao; Lintao Cai |
| 出版日期 | 2015 |
| 会议名称 | ChinaNanomedicine 2015 |
| 会议地点 | Hangzhou, China |
| 英文摘要 | Cisplatin is one of the most widely used agents in the treatment of a variety of tumors. However, its toxicity, cross-resistance, and poor targeting limit application of cisplatin. Furthermore its hydrophilic makes it difficult to encapsulate in nanoparticles (NPs) that maintain adequate concentrations for long time periods. In this report, we applied a cisplatin-prodrug (c,c,t-[Pt(NH3)2Cl2(O2CCH2CH2CH2CH2CH3)2]) approach to enhance cisplatin hydrophobicity，using poly(lactic-co-glycolic acid)（PLGA-lecithin-polyethylene glycol(PEG)-folate(FA) core-shell NPs as the drug carrier. The cisplatin-prodrug loaded PLGA-lecithin-PEG-FA NPs (FA-CPNPs) with different cisplatin-prodrug/PLGA weight ratio had the mean size of 109～122 nm, zeta potentional of -26～-33 mV and polydispersity index of 0.1～0.2 very closed to that of original “empty” NPs. Incorporation of prodrug into PLGA-lecithin-FA NPs enhanced substantially encapsulation efficiency of cisplatin. FA-CPNPs had a much higher uptake rate in MCF-7 cells and accumulation in MCF-7 xenograft tumor than free cisplatin. The cell survival rate assays in vitro and chemotherapy in vivo indicated that the FA-CPNPs could efficiently suppressed MCF-7 cells and xenograft tumor. No noticeable abnormality was observed in heart, liver, spleen, lung and kidneys after the intravenous injection of FA-CPNPs. Our study provided the experiment evidence for the development of novel, effective and safety formulations of platinum drugs. |
| 收录类别 | 其他 |
| 语种 | 英语 |
| 源URL | [http://ir.siat.ac.cn:8080/handle/172644/7435]  |
| 专题 | 深圳先进技术研究院_医药所 |
| 作者单位 | 2015 |
| 推荐引用方式 GB/T 7714 | Mingbin Zheng,Ping Gong,Dongxue Jia,et al. PLGA-lecthin-PEG-folate Core-shell Nanoparticles for Cisplatin-prodrug Targeted Delivery[C]. 见:ChinaNanomedicine 2015. Hangzhou, China. |
入库方式： OAI收割
来源：深圳先进技术研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。